Related Experiment Video
Updated: Aug 11, 2026
06:45
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Postoperative complications in Parkinson's disease
1Dept. of General Internal Medicine, Naval Medical Center San Diego, California 92134-5000, USA.
Journal of the American Geriatrics Society
|August 12, 1999
Summary
Patients with Parkinson's disease face increased risks of longer hospital stays and specific infections after elective surgery. Awareness can improve postoperative care and outcomes for these individuals.
Area of Science:
- Neurosurgery
- Gastroenterology
- Urology
- Epidemiology
Background:
- Parkinson's disease (PD) affects 20 per 100,000 Americans annually.
- Limited data exists on postoperative outcomes for PD patients undergoing elective surgery.
Purpose of the Study:
- To investigate postoperative morbidity and mortality in patients with Parkinson's disease undergoing elective surgery.
- To identify specific complications and length of stay differences.
Main Methods:
- Retrospective cohort study of 41,213 patients undergoing elective bowel resection, cholecystectomy, or radical prostatectomy.
- Utilized Veterans Affairs (VA) database from 1990-1995.
- Employed univariate analysis, multivariate analysis for length of stay, and logistic regression for complications.
Main Results:
- Parkinson's disease patients (n=234) had significantly longer acute hospital stays (11.4 vs 8.8 days, P < .001).
- Higher in-hospital mortality observed in PD patients (7.3% vs 3.8%, P = .006), though not statistically significant after adjustment (P = .098).
- Increased incidence of urinary-tract infection (OR 2.045), aspiration pneumonia (OR 3.825), and bacterial infections (OR 1.682) in PD patients.
Conclusions:
- Patients with Parkinson's disease face elevated risks for specific postoperative complications and extended hospital stays.
- Awareness of these risks can aid caregivers in reducing morbidity, mortality, and hospitalization duration.
- Highlights the need for tailored perioperative management strategies for Parkinson's disease patients.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:23Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...